Some of the UK’s leading aesthetic practitioners gathered in central London on Friday 19th June to celebrate the official launch of babyGLOW™ by Teoxane, marking the introduction of one of the most talked-about innovations in aesthetic medicine this year.
More than 150 guests attended an exclusive evening aboard the luxury river yacht The Silver Sturgeon, cruising along the Thames while experiencing a programme of education, expert discussion, and networking designed to introduce the new technique to the UK market.
The launch event brought together key opinion leaders, clinic owners, and practitioners for an immersive educational experience focused on Teoxane’s latest aesthetic protocol.
The programme opened with an introduction to babyGLOW™ by Teoxane from Dr Raul Cetto, Medical Director at Le Petit Saint, who set the stage for the clinical and aesthetic rationale behind the technique.
This was followed by a thought-provoking session titled “The Patient Perspective”, featuring a discussion between Dr Bibi Ghalaie, owner of Dr Bibi Clinic, and beauty and lifestyle influencer Millie Mackintosh, exploring evolving patient expectations within modern aesthetics.
A key highlight of the evening was an exclusive awards ceremony recognising outstanding practitioners and clinics delivering Teoxane treatments across the UK and Ireland.
Winners included:
The awards highlighted both clinical results and the growing importance of communication, education, and patient engagement in aesthetic practice.
Joanna Underhill, General Manager, Teoxane UK, commented:
“The success of this launch event reflects the passion, creativity, and commitment of the entire Teoxane UK team. We set out to create a memorable experience for our HCP partners and have been delighted by the overwhelmingly positive feedback received from attendees.
Beyond officially introducing babyGLOW™ by Teoxane to the market, this event was an opportunity to bring the industry together, strengthen connections, and celebrate the power of community within aesthetics. Creating these experiences and opportunities that bring together like-minded professionals and encourage the sharing of knowledge and ideas is incredibly important to us and we look forward to building on this momentum in the months ahead.”
Originally launched globally at Teoxane’s dedicated symposium during IMCAS 2026, babyGLOW™ by Teoxane represents a new standardized aesthetic injection technique designed to enhance skin radiance and overall facial freshness.
Developed by a collective of over 15 international aesthetic-medicine experts, including Dr Kieren Bong of Essence Medical in Glasgow, the protocol is designed to be fast, reproducible and easily integrated into existing treatment plans.
Inspired by makeup contouring and highlighting principles, the technique focuses on achieving a natural, luminous result while maintaining facial harmony and safety.
babyGLOW™ is based on a precise anatomical injection approach using a defined set of facial points to optimise product distribution and light reflection.
The protocol is designed to:
By targeting key structural and dermal layers, the technique aims to deliver immediate visible improvements in skin radiance while maintaining a natural aesthetic outcome.
The technique utilises TEOSYAL® Puresense Redensity 1, a non-crosslinked hyaluronic acid formulation enriched with a dermo-restructuring complex of antioxidants, amino acids, vitamins, and minerals.
Its high fluidity supports even dermal and subdermal distribution, promoting hydration, skin redensification and an immediate glow effect with minimal downtime.
babyGLOW™ reflects a broader shift in aesthetic medicine towards skin quality, luminosity and subtle enhancement rather than structural change alone.
With minimal downtime and immediate visible results, the technique is positioned as a practical addition to modern aesthetic treatment portfolios focused on natural-looking rejuvenation.
References